Women over 50 lost 35% more weight with this surprising combo

"Postmenopausal women using menopausal hormone therapy experienced significantly greater weight loss when taking tirzepatide, losing about 35% more weight compared to those using tirzepatide alone."

"These findings point to new possibilities for treating obesity and related health conditions in women after menopause, highlighting the synergy between hormones and weight-loss medications."

"Menopause is often associated with increased weight gain and a higher risk of developing overweight and obesity, which can lead to serious health problems."

""This study provides important insights for developing more effective and personalized strategies for managing cardiometabolic risk in postmenopausal women," says Regina Castaneda, M.D."

A Mayo Clinic study reveals that postmenopausal women using menopausal hormone therapy alongside tirzepatide lost approximately 35% more weight than those on tirzepatide alone. This finding suggests a beneficial interaction between hormone therapy and weight-loss medications, potentially leading to improved treatment options for obesity and related health issues in postmenopausal women. The study emphasizes the importance of personalized strategies to manage cardiometabolic risks associated with menopause, which often includes weight gain and increased health risks such as cardiovascular disease and type 2 diabetes.

Read at ScienceDaily